| Pulmonary Involvement in Systemic Autoimmune Diseases: Volume 2 Contributor(s): Asherson, Ronald (Editor), Doria, Andrea, Pauletto, Paolo |
|
 |
ISBN: 0444516522 ISBN-13: 9780444516527 Publisher: Elsevier Science OUR PRICE: $212.85 Product Type: Hardcover - Other Formats Published: December 2004 Annotation: In this book is found the information essential to diagnosing, managing and treating the lung complications of connective tissue diseases. This is a notoriously difficult area, which continues to puzzle clinicians, despite the fact that these disorders are increasingly frequent (as a result of longer survival in connective tissue disease). In separate chapters, the major connective tissue diseases are reviewed, with detailed discussion of a variety of lung abnormalities, including pleural disease, parenchymal lung disease and pulmonary vascular disease. There are also invaluable overviews of lung histological and CT appearances in these disorders, and a deeply insightful chapter on drug-induced lung disease in connective tissue disease. The emphasis in this book is on accuracy of evaluation and the construction of a logical management plan, based on disease severity and intrinsic progressiveness. |
| Additional Information |
| BISAC Categories: - Medical | Pulmonary & Thoracic Medicine - Medical | Cardiology - Medical | Immunology |
| Dewey: 616.240 |
| LCCN: 2004053790 |
| Series: Handbook of Systemic Autoimmune Diseases |
| Physical Information: 0.69" H x 7.48" W x 10.58" (1.96 lbs) 314 pages |
| Descriptions, Reviews, Etc. |
| Publisher Description: In this book is found the information essential to diagnosing, managing and treating the lung complications of connective tissue diseases. This is a notoriously difficult area, which continues to puzzle clinicians, despite the fact that these disorders are increasingly frequent (as a result of longer survival in connective tissue disease). In separate chapters, the major connective tissue diseases are reviewed, with detailed discussion of a variety of lung abnormalities, including pleural disease, parenchymal lung disease and pulmonary vascular disease. There are also invaluable overviews of lung histological and CT appearances in these disorders, and a deeply insightful chapter on drug-induced lung disease in connective tissue disease. The emphasis in this book is on accuracy of evaluation and the construction of a logical management plan, based on disease severity and intrinsic progressiveness. |
